News from neuralstem, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 30, 2014, 09:15 ET

Neuralstem Added To Russell 3000 Index

 Neuralstem, Inc. (NYSE MKT: CUR) reports that its shares have been added to the broad-market Russell 3000® Index. Annual...

Jun 25, 2014, 09:15 ET
Neuralstem Logo. (PRNewsFoto/NEURALSTEM, INC.)

Neuralstem's NSI-189 Novel Neurogenic Compound Shows Significant Effect In Major Depressive Disorder

 Neuralstem, Inc. (NYSE MKT: CUR) announced that two sets of data from the NSI-189 clinical trial in major depressive disorder (MDD) were...

Jun 19, 2014, 09:15 ET
Neuralstem Logo. (PRNewsFoto/NEURALSTEM, INC.)

Neuralstem NSI-189 Select Data To Be Presented At Neuropsychopharmacology Congress

 Neuralstem, Inc. (NYSE MKT: CUR) announced that select data from the NSI-189 Phase Ib trial in patients with major depressive disorder (MDD)...

Jun 18, 2014, 09:15 ET

Neuralstem Final Phase I Depression Data Presented At The American Society Of Clinical Psychopharmacology Annual Meeting

 Neuralstem, Inc. (NYSE MKT: CUR)  announced that final data from the Neuralstem NSI-189 Phase Ib study in major depressive disorder (MDD)...

May 23, 2014, 09:28 ET
Neuralstem Logo. (PRNewsFoto/NEURALSTEM, INC.)

Neuralstem Depression Trial Data to Be Presented at The American Society of Clinical Psychopharmacology Annual Meeting

 Neuralstem, Inc. (NYSE MKT: CUR) announced that data from the NSI-189 Phase Ib study in major depressive disorder (MDD) will be presented at...

May 16, 2014, 09:15 ET
Neuralstem Logo. (PRNewsFoto/NEURALSTEM, INC.)

Neuralstem CEO, Richard Garr, to Present at World Stem Cells & Regenerative Medicine Congress and Give Update on Trials

 Neuralstem, Inc. (NYSE MKT: CUR) CEO and President, Richard Garr, will present at the World Stem Cells & Regenerative Medicine Congress,...

May 12, 2014, 09:15 ET
Neuralstem Logo. (PRNewsFoto/NEURALSTEM, INC.)

Neuralstem Reports First Quarter Financial Results And Provides Business And Clinical Update

 Neuralstem, Inc. (NYSE MKT: CUR) today reported its financial results for the three months ended March 31, 2014 and provided a business and...

May 08, 2014, 09:15 ET
Neuralstem Logo. (PRNewsFoto/NEURALSTEM, INC.)

Neuralstem Appoints Sandford Drexel Smith, Former Genzyme Executive Vice President, To Board Of Directors

 Neuralstem, Inc. (NYSE MKT: CUR) announced the appointment of Sandford Drexel Smith to its Board of Directors, bringing the total number of...

Apr 16, 2014, 09:15 ET
Neuralstem Logo. (PRNewsFoto/NEURALSTEM, INC.)

Neuralstem Spinal Cord Injury Stem Cell Trial Approved To Commence At University Of California, San Diego

Neuralstem, Inc. (NYSE MKT: CUR) announced that the Institutional Review Board of the University of California, San Diego, School of Medicine has...

Apr 07, 2014, 09:15 ET
Neuralstem Logo. (PRNewsFoto/NEURALSTEM, INC.)

Neuralstem Principal Investigator, Dr. Eva Feldman, To Present Published ALS Trial Phase I Data At Medical Conference

 Neuralstem, Inc. (NYSE MKT: CUR) announced that Eva Feldman, PhD, MD, principal investigator of Neuralstem's NSI-566 stem cell...

Mar 28, 2014, 09:15 ET
Neuralstem Logo. (PRNewsFoto/NEURALSTEM, INC.)

Study Shows Neuralstem Cells Transplanted Into Brain Significantly Improve Post-Stroke Symptoms in Rats

 Neuralstem, Inc. (NYSE MKT: CUR) announced that a study published in the peer-reviewed journal, PLOS ONE, showed that ischemic-stroke rats...

Mar 17, 2014, 09:15 ET
Neuralstem Logo. (PRNewsFoto/NEURALSTEM, INC.)

Final Results Of Neuralstem Phase I Stem Cell Trial In Amyotrophic Lateral Sclerosis Published In Annals of Neurology

 Neuralstem, Inc. (NYSE MKT: CUR) announced that the final results from the Phase I safety trial using NSI-566 spinal cord stem cells in the...

Mar 10, 2014, 09:00 ET
Neuralstem Logo. (PRNewsFoto/NEURALSTEM, INC.)

Neuralstem Announces 2013 Financial Results

 Neuralstem, Inc. (NYSE MKT: CUR) today provided an update on its clinical trials program and reported its 2013 financial results for...

Feb 06, 2014, 09:00 ET
Neuralstem Logo. (PRNewsFoto/NEURALSTEM, INC.)

Neuralstem President and CEO to Present NSI-566 Clinical Trials Program Update at BIO CEO & Investor Conference 2014

Neuralstem, Inc. (NYSE MKT: CUR) announced that President and CEO Richard Garr will present at the 16th Annual BIO CEO & Investor...

Jan 14, 2014, 09:00 ET
Neuralstem Logo. (PRNewsFoto/NEURALSTEM, INC.)

Neuralstem Appoints Catherine Angell Sohn To Board Of Directors

 Neuralstem, Inc. (NYSE MKT: CUR) announced the appointment of Catherine Angell Sohn, Doctor of Pharmacy (Pharm.D.), to its Board...

Jan 13, 2014, 15:50 ET
Neuralstem Logo. (PRNewsFoto/NEURALSTEM, INC.)

Neuralstem President And CEO To Present 2014 Trials Overview At 2014 Biotech Showcase

 Neuralstem, Inc. (NYSE MKT: CUR) announced that President and CEO Richard Garr will present at the sixth annual Biotech Showcase...

Jan 13, 2014, 09:46 ET
Neuralstem Logo. (PRNewsFoto/NEURALSTEM, INC.)

First Patient Treated In Neuralstem China Stem Cell Trial To Treat Stroke Motor Deficits

 Neuralstem, Inc. (NYSE MKT: CUR) announced that the first patient was treated in the Phase I/II NSI-566 stem cell trial to treat motor...

Jan 09, 2014, 09:00 ET
Neuralstem Logo. (PRNewsFoto/NEURALSTEM, INC.)

Neuralstem Closes $20 Million Registered Direct Offering

 Neuralstem, Inc. (NYSE MKT: CUR) announced today that on January 8, 2014, it closed on a $20 million investment from leading...

Jan 03, 2014, 09:00 ET
Neuralstem Logo. (PRNewsFoto/NEURALSTEM, INC.)

Neuralstem To Raise $19.65 Million In Registered Direct Offering

 Neuralstem, Inc. (NYSE MKT: CUR) announced today that it has entered into agreements with leading institutional investors for a...

Nov 12, 2013, 16:46 ET
Neuralstem Logo. (PRNewsFoto/NEURALSTEM, INC.)

Neuralstem Reports Third Quarter Financial Results And Provides Business And Clinical Update

 Neuralstem, Inc. (NYSE MKT: CUR) today reported  financial results for the three months and nine months ended September 30, 2013 and...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge